Topic: Salim Abdool Karim

Trials of microbicide gels to protect women against HIV infection have a perfect record--not one of them has worked, and some were even harmful. As reported here today at the 16th Conference on Retroviruses and Opportunistic Infections, the study showed that a ...
A widely anticipated presentation here at the 18th International AIDS Conference turned out to be doubly sweet. Quarraisha and Salim Abdool Karim, the husband-and-wife team who led the study, called CAPRISA 004, presented the bulk of the data during an afternoon session ...
A vaginal gel applied consistently before and after sex reduced the risk of HIV infection by more than half, according to a study presented Monday at the International AIDS Conference in Vienna.. Despite these promising results, the gel still needs to be ...
A widely anticipated presentation here at the 18th International AIDS Conference turned out to be doubly sweet. Quarraisha and Salim Abdool Karim, the husband-and-wife team who led the study, called CAPRISA 004, presented the bulk of the data during an afternoon session ...
A vaginal gel applied consistently before and after sex reduced the risk of HIV infection by more than half, according to a study presented Monday at the International AIDS Conference in Vienna.. Despite these promising results, the gel still needs to be ...

Major step seen in quest for anti-HIV vaginal gel

Scientists on Monday reported a major stride towards a vaginal gel that can thwart HIV, a goal that would be of huge benefit to African women bearing the brunt of the AIDS pandemic.A prototype cream tested in South Africa reduced risk of ...

AIDS gel with Gilead drug protects women in study

WASHINGTON (Reuters) - A protective gel made using Gilead Sciences Inc's HIV drug tenofovir reduced HIV infections in women by 39 percent over two and a half years -- the first time such an approach has protected against the AIDS virus, South ...
A vaginal microbicide can cut HIV infection rates by 39 percent in women, researchers announced Monday. It was tested, starting in 2007, in a double-blind, randomized controlled trial of 889 sexually active women ages 18 to 40, in the KwaZulu-Natal province, which ...
US company's AIDS-fighting gel for women offers some hope in preliminary five-country studyAn experimental vaginal gel has shown some promise in preventing infection from the AIDS virus the first study to offer hope that a microbicide may soon join the medical arsenal ...